| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,479,000 | 1,395,000 | 989,000 | 1,084,000 | | Cost of Revenue | 880,000 | 820,000 | 719,000 | 777,000 | | | Gross Profit | 599,000 | 575,000 | 270,000 | 307,000 | | | Operating Expenses | | Research Development | 131,000 | 136,000 | 151,000 | 153,000 | | Selling General and Administrative | 219,000 | 211,000 | 207,000 | 179,000 | | Non Recurring | 16,000 | 5,000 | 169,000 | (6,000) | | Others | 3,000 | 2,000 | 3,000 | 4,000 | | | | Total Operating Expenses | 369,000 | 354,000 | 530,000 | 330,000 | | | | Operating Income or Loss | 230,000 | 221,000 | (260,000) | (23,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 53,000 | 45,000 | 27,000 | (22,000) | | Earnings Before Interest And Taxes | 699,000 | 627,000 | (38,000) | (45,000) | | Interest Expense | 24,000 | 20,000 | 14,000 | 11,000 | | Income Before Tax | 675,000 | 607,000 | (52,000) | (56,000) | | Income Tax Expense | 32,000 | (4,000) | (66,000) | (23,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,617,000 | 611,000 | 14,000 | 249,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 643,000 | 611,000 | 14,000 | 249,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $643,000 | $611,000 | $14,000 | $249,000 |
|
2.03% Nasdaq 
Income Statement
